A Psychedelic Development and Wellness Company

Trip Pharma is currently pursuing the buildout of a purpose-built facility that will provide a supply of high-quality products for use in research and prescription for clinical patients. Trip Pharma intends to conduct research in psilocybin producing mushrooms, is in the process of submitting an application for a Controlled Drugs and Substances Dealers License in Canada and is working to source a library of Psilocybin Cubensis genetics.

Trip Pharma also plans to develop a psychiatric research clinic where patients are able to access care, as well as complementary treatments, in a welcoming and stigma-free environment. If and when Trip Pharma receives its dealers license, the clinic intends to conduct research into the use of psilocybin for the treatment of depression, anxiety, post-traumatic stress, chronic pain and fatigue, sleep disorders, sexual dysfunction, and attention deficit symptomatology, and then meet with patients to gauge their interest in the use of psilocybin as a potential therapy.

LEARN MORE

Our Clinic

Led by Dr. Krista Leicht, our clinic is a multidisciplinary clinic, on the cutting edge of innovative treatments. We offer patients alternatives to conventional psychiatric and medical therapy for a wide variety of issues and conditions.

Aimed to offer both conventional and alternative therapies to help treat depression, mood disorders, anxiety, metabolic dysregulation and chronic pain among many others.

LEARN MORE